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As the UK reiterates its commitment to protecting and growing its development aid budget amidst an adverse
economic environment for the UK and Europe, we discuss the potential to use the country’s National Health
Service (NHS) model as a vehicle for promoting the country’s economic as well as global health diplomacy and
development priorities, through a coordinated cross-government plan of action. With the country’s Prime Minister
serving as a co-chair of the UN post-2015 development agenda panel,a this is a unique opportunity for the UK to
put forward its health system architecture as a highly applicable and well-tested model for providing access to
efficient and cost-effective care, with minimal financial hardship. Arguably, such a model tailored to the needs of
specific countries could consequently lead to commercial opportunities for UK plc. in areas such as consulting,
training, education and healthcare products. Finally, this approach would be consistent with the current thinking on
the evolving role of UK aid, especially in the case of emerging powers such as India, where the focus has shifted
from aid to investment in technical assistance and cooperation as a means of boosting bilateral business and trade.
Keywords: National Health Service, Universal Healthcare Coverage, Global health diplomacyThe NHS as a trade, foreign and global
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In December 2012, the United Nations’ General Assembly
voted in favour of a resolution for Universal Health Cover-
age (UHC) [1], firmly placing the UHC movement at the
centre of the discussions on what takes the place of the
Millennium Development Goal framework [2] come 2015.
A few days later, the US State Department set up a new of-
fice of Global Health Diplomacy and appointed its first
ever Global Health Ambassador to: “…work with ambas-
sadors to build political will in countries, in pursuit of sus-
tainable health systems without barriers to care” [3].
As the UK reiterates its commitment to reaching the
0.7% GDP target for its development assistance, despite
the adverse economic environment for the UK and Europe,
we believe that the NHS can serve as a vehicle for promot-
ing the UK’s trade, health diplomacy and global develop-
ment priorities, through a coordinated, strategic long-term
plan of action, cutting across government departments.
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distribution, and reproduction in any mediumNHS model stemming from an enhanced UK brand, stron-
ger governance and regulation and ability to influence the
structures of some of the largest and fastest growing mar-
kets in the world, as well as from direct commercial oppor-
tunities for UK universities, hospitals and consultancies.
Furthermore, there are also major philanthropic and
foreign policy benefits of such a coordinated effort for
sharing the (good and bad) lessons of a National Health
Service. These include helping address the Department for
International Development objective of reducing poverty
through establishing fair and equitable health systems
which protect individuals from financial catastrophe and
offer care to those in need. At a time when aid initiatives
in emerging markets are being scaled down, NHS know-
how sharing can lead to the development of Southern cen-
tres of excellence for supporting the transition towards
UHC, both technically and in terms of process.
Added to the philanthropic objectives, there are foreign
policy and diplomacy ones: global health diplomacy is a
growing field, with the US having recently appointed a
Global Health Ambassador accountable to the country’s
Secretary of State. The UK Government can benefit from a
more proactive approach to relationship building through
sharing sought after experiences of the NHS (see Figure 1).Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Getting the balance right. The National Health Service can serve as a means of meeting the triple objective of poverty eradication
and development through universal coverage; global health diplomacy and relationship building; and, improving trade and the UK’s commercial
interests overseas.
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the NHS stands to learn from others and benefit as it is
entering an era of significant underfunding.b
Moving towards universal health coverage:
the global momentum
The World Health Organisation defines Universal Health
Coverage, as: “…securing access for all to appropriate pro-
motive, preventive, curative and rehabilitative services at
an affordable cost” [4]. As such, UHC incorporates both
protection from catastrophic costs [5] as well as access to
good quality care for all those who need it [6].
The global movement for UHC is gaining momentum.
In their first ever Health Summit, held in Beijing in
2011, the Health Ministers from all 5 BRICS countries
reaffirmed their commitment to working together and
with other countries to ensure equitable access to “medi-
cines and health commodities”.c National health reforms
in the co-called emerging powers, are on-going. China is
rolling out an innovative multi-billion health insurance
scheme to cover its 850 million rural citizens [7]. In its
12th Plan, India recently announced its commitment
to achieve UHC by doubling the public funds spent on
healthcare to over 2% of the country’s GDP [8,9]. Turkey is
about to declare (and celebrate) Universal Coverage in
2013, and Mexico [10], Chile [11] and Thailand [12] are
major success stories in offering healthcare and financial
protection from health spending, to all of their citizens.
South Africa, Indonesia, Ghana, the Philippines, are some
of the many low and middle income countries whose gov-
ernments are now legislating and mobilising resources toreach the UHC goal within the coming years [13]. The
United States of America is also working toward expanding
access during the second Obama Administration [14].
The British National Health Service: focus on
quality, efficiency and access…
Set up immediately after the 2nd World War, and built
on the principles of equity and solidarity, the British Na-
tional Health Service is the largest and one of the oldest
single-payer publicly funded national healthcare systems
in the world. For over 60 years, the NHS has remained
true to its core principles of comprehensiveness and uni-
versality, which, amongst other attributes, such as minimal
out-of-pocket contributions and no or nominal fees at the
point of care, make it a successful model to provide uni-
versal health coverage to the UK citizens, most remarkably
as the UK has just below average OECD levels of spending
on healthcare. As it stands today, the NHS is defined by a
set of attributes, determined to an extent by contextual
factors such as custom, feasibility, resources and prevailing
ideology, some of which (such as the ownership of the
delivery agents) have changed over the years.
However, recent reforms may have, according to some,
challenged some of the NHS’s core attributes [15]. Changes
brought about by the Coalition government regarding the
way care is purchased (GPs now have responsibility for
the bulk of NHSs budget) and even delivered with an in-
creasing role for private providers and a push towards
competition between institutions, may seem to be under-
mining some of the core founding principles of the NHS
and have fuelled a bitter and highly polarised debate.d
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NHS, though its budget has been ring-fenced, is faced with
significant efficiency savings, making restructuring amidst
a shrinking (given the growing demand) budget, all the
more challenging [16].
Interestingly, the reforms have triggered the interest of
overseas policy makers who want to understand the ar-
guments on both sides and the government’s rationale,
and assess the relevance of the reforms to their own set-
ting. Overall, and despite recent changes, in the eyes of
many LMIC governments and citizens, the NHS and its
core and core attributes, represent a successful, British
application of the UHC model.
The UK NHS scores consistently high on international
benchmarking comparisons of health system performance
across developed countries [17,18] especially on equity, in-
tegration, macro efficiency and cost effectiveness.
In addition, almost 65 years on, the NHS enjoys high
levels of public satisfaction (~60% in 2011 and ~70% in
2010 [19]) and broad cross-party support.
Furthermore, the UK has a strong reputation in basic
science and clinical research; an internationally renowned
tradition in professional training and clinical governance;
and a track record in evidence-informed policy and
practice. Arguably, the NHS is the backbone of this
success. With its Royal Colleges and medical schools,
its standard-setting institutions, such as the National
Institute for Health and Care Excellence (NICE), its
strong commitment to research through its research
councils and the National Institute for Health Research,
its recent policy reforms in areas such as governance (e.g.
Foundation Trusts, NHS Commissioning Board) and
provider payment (e.g. Payment by Results, Quality and
Outcomes Framework, Clinical Commissioning Groups),
and its primary care-centred approach to prevention
and management, the NHS regularly attracts interestTable 1 Core attributes of the National Health Service, reflect





Universality All residents of th
User fees Care is free at the
Funding source Progressive gener
Resource allocation Centralised resourc
Purchasing/commissioning NICE explicitly acc
and technologies
Ownership of healthcare delivery agents Mix of public, priv
NHS patients base
Co-existence with private system Small (and shrinki
exists for British tafrom policy-makers and professionals from around the
world.
…and a (surviving) commitment to equity
Out of all the attributes set out above and in Table 1,
the ones that differentiate the NHS from other systems
that have also reached universality of coverage, and which
are perhaps more relevant to the UHC movement, are its
equity in financing (the way resources are raised and
pooled and how this affects the most vulnerable groups in
the society) through progressive general taxation and its
equity in resource allocation (the way resources are man-
aged and shared out between different geographical re-
gions, population groups and then invested in, through a
purchasing function, specific technologies and services).
Providing 100% effective and equitable coverage at
relatively low cost is perhaps what makes the NHS most
attractive to developing country politicians, faced with
the challenge of sustaining ever increasing costs in sys-
tems with relatively small formal sectors and weak ad-
ministrative and information systems, hence making
taxation a simple and attractive model. Indeed, Mexico,
Brazil, Turkey and Thailand are UHC success stories,
where taxation has been the major source of funding.
On resource allocation, the NHS has applied tools
such as the Resource Allocation Working Party (RAWP)
Formula, which since the mid 70s aims to allocate funds
to local areas so that ‘…there would eventually be equal
opportunity of access to health care for people at equal
risk’. In the late 90s, the Labour government introduced
another objective of resource allocation: ‘to contribute to
the reduction in avoidable health inequalities’ and whilst
this has been down-weighted by the current Coalition
government, it remains a driving principle of resource al-
location [20]. In addition to the allocation formula which
explicitly considers need, another policy interventioning one possible (and fairly successful) implementation of
stem, covering effective and cost-effective health care, public health and
ocial care. In the ‘ultimate’ case, ‘comprehensiveness’ embraces all health
pre-natal to the grave.
e UK (citizens, legal and illegal immigrants) are covered.
point of use
al taxation funding
e allocation formula which takes account of need, deprivation, market forces
ounts for the opportunity cost of new investment decisions in services
ate and third sector, all under contractual arrangements to offer care to
d on fee schedule and quality standards
ng) private market co-exists with the NHS but no opt-out of the NHS
x-payers
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for Health and Care Excellence (NICE) also emphasises the
NHS’s commitment to taking account of the opportunity
cost of every investment decision in healthcare. NICE aims
to ensure that the NHS only invests in technologies and
services that are proven to work for its population and that
are good value for money. Equal access for equal need
(in its clinical programmes) and an explicit objective to
targeting disadvantaged groups (in its public health and
possibly newly introduced social care programmes) are
key driving principles for NICE [21,22].
Growing global influence
Historically countries like Chile, as well as Cuba and Sri
Lanka, were amongst the first to emulate the British model
characterised by universal coverage, funded by general tax-
ation, free at the point of service, and public ownership
and/or regulation of health care delivery of services. Sev-
eral others, such as Germany, Japan, and the Netherlands,
introduced social insurance models based on prepaid con-
tributions and mixed delivery of health care through public
or private providers [23-25].
Free-market reforms in the 80s and 90s, often in the
form of structural adjustment programmes advocated by
donors, may have compromised the principles of access
and solidarity. China is perhaps the biggest example of a
whole country abandoning its communal model only to re-
invent in the late 90s as the New Cooperative Medical
Scheme and invest heavily in it since, as a means of cover-
ing the whole of its rural population [26]. The UK perhaps
played a more active role in influencing this decision
through a little-advertised 5-year DFID-sponsored prog-
ramme, the Health Policy Support Project, which helped
the Government of China decide, based on evidence from
8 countries, including the UK, to re-socialise its health fi-
nancing system with an injection of $140 Billion of tax
funding in 2009, with a growing annual tax-funded com-
mitment to healthcare, every year since.e
As the UHC movement gains momentum, there has
been a rapidly growing demand for technical support
from many of the institutions that compound the NHS,
including its National Institute for Health and Clinical
Excellence [27], has been growing. Colombia launched
in 2012, IETS, a priority setting institution modelled
along the lines of the NHS’s NICE [28] to support prior-
ity setting across its insurance plans. The Government
of India announced in its 12th Plan [9], its commitment
to UHC along with its ambition to set up a NICE [29].
China, following almost 3 decades of market reforms, is
now investing in a system with great government involve-
ment and less out of pocket contributions, much closer to
the British, including a Chinese version of NICE [7]. The
influence of the NHS extends also to the international press
and blog sites. Countries like China, Brazil and Chile,heavily featured and celebrated the British people’s affection
of the NHS as reflected in the 2012 Olympic opening
ceremonyf [30]. And whilst history and the political
economy of the UK and of England in particular have de-
termined the birth and evolution of the NHS and are highly
context specific, countries share both values (solidarity,
universality) and technical challenges (efficient financing
and allocation), making cross country comparisons and
know-how sharing, a popular and most likely useful activity.
Despite the burgeoning demand from countries moving
towards UHC, sharing, through a single cross-government
strategy, the UK system’s approach and know-how for
building an integrated quality-driven national health sys-
tem, has not been a government priority. There have been
few government and third sector-sponsored initiatives over
the past few years, aiming to promote some aspects of the
NHS and the British healthcare industry. These include re-
cently launched Healthcare UK, with an explicitly commer-
cial short-term focus on catalysing business deals, the
India-UK CEO’s Forum, with support from the Wellcome
Trust for its health stream [31], and the DFID-sponsored
Health Partnerships Scheme [32], unique in its NHS focus
but relying on NHS staff volunteering their time and with
an allocation of less than 0.06% of DFID’s annual budget.
Perhaps the most ambitious, strategic and cross-cutting
amongst these initiatives, the Department of Health’s Glo-
bal Health Strategy, which includes all three, diplomatic,
trade and development objectives, seems to lack the
dedicated resources needed to deliver [33]. Some of these
initiatives are further discussed, along with their advantages
and weaknesses, in Table 2.
The NHS as a catalyst for commercial opportunities
When it comes to the NHS, the UK has been putting
increasing weight on the commercial, and often short-
term and fragmented, side of global health, such as dir-
ectly promoting British-made electronic medical record
systems, medical tourism in the UK or abroad or large
construction firms [34-37]. In the current economic down-
turn such an approach is perhaps understandable. How-
ever, commercial inroads are more likely to be achieved in
an environment of broader engagement. Sharing the NHS
thinking and overall architecture could be the first step in
a broader relationship building strategy that will include
but will not be driven by commercial interests. Promoting
the NHS model, through a coherent cross-government
strategy, as a highly applicable and well tested means for
effectively financing a universal coverage system providing
access to cost-effective care, could consequently lead to
broad commercial opportunities for the UK in areas such
as consulting, training, education and healthcare products.
This approach is likely to benefit a number of UK sectors,
including UK Universities (medical and nursing schools as
well as epidemiology and statistical departments, schools
Table 2 Recent initiatives by Her Majesty’s Government for promoting the NHS overseas
National policy or initiative Brief description and challenges Government or other sponsor
Health Partnerships Schemeo Aims “to support the development of health services in some
of the world’s poorest countries” drawing on the experience
of the NHS, academe and professional organisations.
Department for International Development –
DFID; (NHS organisations and employees)
Relies largely on NHS (or individuals) volunteering their time/resources:
challenging in current financial environment and may undermine
longer-term sustainability of partnerships esp. in sub-Saharan Africa.
Health is Globalp An attempt to articulate a cross-government vision for global
health, through an outcomes framework for global health
(2011–2015) setting out set out how UK Government departments
should work together coherently to improve health in the UK
and overseas
Department of Health – DH; (DFID)
An independent review of the strategy highlighted lack of
cross-government coordination, leadership and UK institutional
champions and a lack of financial [33].
Global Development Partnerships
Programmeq
Aimed at ensuring coordination between DFID and other
government departments and No 10, with an emphasis on
DFID’s engagement with emerging powers and a view to
catalyse South/South partnerships and boost the civic/donor
responsibility of the BRICS countries.
DFID
Healthcare UK New (Dec 2012) unit jointly sponsored and resourced by UKTI
and DH and hosted by UKTI aimed at exporting UK expertise
in healthcare (NHS and commercial), through a project-specific
high priority country approach.
UK Trade and Industry/BIS; (DH)
No explicit relationship building or development focus. Fragmented
and somewhat short-termist
NHS Globalr Predecessor to Healthcare UK, with a predominantly commercial
focus aimed at supporting NHS-span businesses abroad
NHS (FCO; UKTI/BIS)
Was commercial remit and short term in its outlook – it has
now been terminated
India – UK CEO Forums Established by the British and Indian Prime Ministers in 2010
to help achieve the two governments’ aim “to be ambitious in
seeking to substantially increase trade and significantly increase
investment between the UK and India”. Health identified as one
of 4 key priorities [31].
Government of India – UK Government;
Lack of dedicated seed funding on the UK side – some initiatives
such as primary care pilots in Kerala have been completed but
unclear how they can now be scaled up/taken forward.
For health: Wellcome Trust and No 10;
(DH; UKTI; FCO; DFID)
Innovation, Health and Wealtht NHS strategy (Dec 2011) for embracing and embedding
innovation across the NHS, improving outcomes and driving
growth for the UK. Sets out a requirement for NHS organisations
to increase national and international activity” with a focus on
commercial income generating opportunities.
NHS; (UKTI)
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Colleges and the recently launched Academic Health Sci-
ence Networks.
The medium-term benefits are also likely to be signifi-
cant for the broader healthcare industry and third sec-
tors involved in commissioning and provision, as well as
infrastructure, telecom and IT, administration and out-
sourcing, and manufacturing of medical devices, pharma-
ceuticals and diagnostics. The UHC global agenda has
opened up the prospects of significantly larger markets.
Where the underpinning governance, purchasing and
provision model are that of the British NHS, UK businesses
are likely to benefit from familiar regulatory, financing and
care delivery frameworks, including NICE-like systems forassessing value-for-money, and from a workforce which
has been trained in and trusts the quality and evidence-
informed care delivered by the NHS.
Furthermore, with innovation increasingly taking place
outside the developed world and growing challenges to
the intellectual property by developing country govern-
ments and their home-grown industry, strong partnerships
which share the NHS as the preeminent model, are per-
haps more likely (than aggressive litigation or restrictive
Free Trade Agreements) to open channels of communica-
tion and generate potential for joint ventures, outward in-
vestment and win-win know-how transfer deals, such as
the one between GSK and the Brazilian Government on
the HPV and Dengue vaccines [38,39].
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emerging powers
In his Emerging Powers speech in June 2011, the then
Secretary of State for Development described a changing
world where relationships between the UK and emerging
powers: “…will become less rigid and more equal” and
where “aid will be but one of our tools. We will trade in
ideas and in expertise too, and we will broker political
support and create coalitions to tackle specific issues.”g
Know-how transfer in setting up and running a suc-
cessful UHC system drawing on the experience of man-
agers, clinicians, researchers, civil servants and policy
makers working in or with the NHS, is less expensive
and more appropriate than direct purchasing of com-
modities for all but the poorest of countries DFID operates
in. For example, instead of purchasing pharmaceuticals on
behalf of upper-middle income economies, the UK can
help inform their governments’ decisions on formulary
listing, procurement, pricing and reimbursement and
evidence-based prescribing and use and build local tech-
nical and institutional capacity for making these decisions
in the future. In a country like India, where 70% of all
healthcare spending is out of pocket and over 70% of
that goes towards purchasing pharmaceuticals, efficient,
evidence-based procurement and use can release resources
for expanding coverage to more people and investing in
necessary technologies and services. The shift towards
technical assistance focused on high priority areas includ-
ing health and applying a cross-government approach, was
announced by the Secretary of State for Development in
her recent visit to India.h In the same spirit, in February
2013, DFID announced the establishment of a tax capabil-
ity unit within HMRC and further investment in DFID’s
international growth centre, offering policy advice to
governments on effective tax and growth policies, respect-
ively.i In a similar vein, though since scrapped, the previous
administration set up the Centre for Progressive Health Fi-
nancing to support countries achieve UHC [40].
Through forging functional partnerships, building trust
and boosting governance and technical and administrative
capacity, particularly in relation to emerging powers such
as India and China, DFID can achieve its multiple objec-
tives of:
 Catalysing South-South partnerships and boosting
middle income countries’ ability to serve as value-
adding responsible donors towards poorer states
[41], also keenly interested in how China or Brazil
have achieved UHC. This would also mean that the
UK’s development agenda is sustained, even if DFID
support is scaled down in the future.
 Facilitating exit strategies for DFID from providing
expensive health sector inputs in middle income
countries which should be replacing aid financingwith domestic revenues, and optimising their
spending through applying know-how from the UK
as well as emerging Southern centres of knowledge
(see earlier point).
 Delivering its poverty reduction agenda through
supporting equitable and efficient UHC. Efficient
resource allocation and scientifically robust and fair
processes for setting priorities for what ought to be
included in a basic benefits package, can serve as
“equalisers” and means of domestic redistribution of
resources and wealth within the so-called emerging
economies, where the vast majority of world’s poor
live [42].
 Ensuring the UK itself achieves demonstrable Value
for Money, through promoting to key partners such
as GAVI and the Global Fund, making significant
investment on its behalf, the kind of economic
evaluation the NHS, through NICE, applies before
making major technology adoption decisions.
Demonstrating value-for-money is an imperative,
especially as DFID’s resources are being ring-fenced
at a time of persistent economic recession back home.
Aid for trade?
DFID is increasingly keen on using growth as a vehicle
for development including through promoting British
companies overseas.j To achieve this, DFID acknowl-
edges the importance of strong governance and regula-
tion and is committed to helping build institutions to
promote inclusive growth.k In healthcare in particular,
institutions like NICE that empower policy makers make
wise investment decisions in an inclusive and procedur-
ally fair fashion, are prerequisites for British industry,
including large Pharma, expanding overseas in an ethical
and beneficial for all, way.
This approach may also appeal to social impact inves-
tors, attracting capital for reinvesting into basic social
objectives such as Universal Coverage and efficient health-
care systems through an authoritative peer-to-peer model
of support which may develop into an income generating
activity servicing large donors and multinationals as well as
governments of emerging economies.
Global Health Diplomacy: effective
relationship-building
Diplomacy as a means of strengthening global health has
been featuring high on the foreign policy agenda of the
United States. The recent (Dec 2012) appointment of
the first ever US Global Health Ambassador at the newly
launched Office of Global Health Diplomacy to: “…guide
diplomatic efforts to advance the United States’ global
health mission to improve and save lives and foster sus-
tainability through a shared global responsibility”,l and
the State Department’s sustained focus on global health
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a safer, more secure world”,m are evidence of this. The
UK can learn from the Americans as well as other major
players such as Brazil [44] and Cuba,n and use one of its
most strategic assets, the NHS, in exerting global health
diplomacy as a means for improving health and as a dip-
lomatic end in itself.
Healthcare and affordable and high quality UHC fea-
ture highly in bilateral and multilateral fora (e.g. WHO/
WHA; UN General Assembly) and High Level Economic
Talks and Policy Dialogues, between countries, especially
amongst the so-called emerging powers, which the UK
is keen to influence. Indeed, recently signed Memoranda
of Understanding between the UK and Mexico, Brazil,
India and China all place particular emphasis on health
systems and highlight the NHS as a resource for informing
those countries’ own national reforms towards UHC.
A coordinated systems’ approach on the part of the
British Government, including know-how transfer, shar-
ing of information and data and exchanges and staff
training programmes (for policy makers, clinicians and
administrators) is likely to strengthen bilateral links at a
small incremental cost to the British system. In turn,
such engagement may offer potential openings for diplo-
matic dialogue in other, high priority areas for the UK,
including trade, the environment and security.
Learning from others
In an increasingly multicultural environment, the NHS
can learn a lot about accessing socially vulnerable groups
through engaging internationally. Poorer systems often
develop coping mechanisms for managing under re-
source constraints, which may help the NHS adapt to its
shrinking budget (e.g. more effective use of theatres, task
shifting away from doctors and application of inexpensive
technologies in the community setting) [45]. Though not
as obvious perhaps a connection as with infectious disease
outbreaks, addressing NCDs, enhancing access to afford-
able new technologies and reducing inequalities, are im-
portant and shared global challenges, potentially more
effectively be tackled collaboratively, across rich and
poorer countries. Experiences from the NHS’s volunteer-
ing programme have been most encouraging, leading the
All Party Parliamentary Committee for global develop-
ment to call for the “…NHS England, the Department of
Health and other national health bodies [to] reinforce the
value and legitimacy of NHS involvement in global health
by sustaining and extending successful policies” [46]. We
believe such meaningful two way learning can be one posi-
tive externality of “exporting” the NHS model, and re-
quires investment on the part of the NHS in systematically
identifying the lessons from developing countries’, and
then adapting them to the UK setting and evaluating their
impact. Most importantly, it requires a change in the NHSmentality, opening up to the possibilities of learning from
colleagues operating in less developed and more resource
constrained realities.
Focusing on the how
Helping build functioning primary care systems and re-
focusing care away from tertiary hospitals and towards pre-
vention and the outpatient setting; strengthening hospital
governance and provider payment mechanisms; sharing
experiences on pay for performance schemes and on qual-
ity standards; improving the efficiency of pharmaceutical
listing decisions and helping train the next generation of
healthcare professionals and ministry analysts, are only
part of what UK technical assistance can achieve, all major
building blocks of strong and sustainable UHC systems.
Such relationship-building through sharing the NHS
model is also consistent with the British NHS’s public
sector ethos and capabilities. Conversely, direct promo-
tion of private goods is arguably better done by the pri-
vate sector itself, which is also better at raising capital
and taking risks when investing overseas.
Conclusions
In an increasingly multicultural environment, the NHS can
learn a lot through engaging internationally [45]. It may
also be that, as the NHS learns more about the challenges
other countries face, and how others view what has been
achieved in the UK, the British policy makers come to
value and perhaps better safeguard the most important
aspects of their own system or become less prone to con-
tinuously restructuring it.
Using government funds to support ‘public-public’
partnerships between the NHS and overseas healthcare
systems is likely to improve diplomatic relations, spilling
over to sectors beyond health and generating trade
opportunities. This can be an inexpensive way to both
respond to a well-articulated global demand and to build
UK’s capacity better to share its expertise and experience
with its overseas partners, as well as its ability to assess
its own impact and learn in the process.
Lastly, under the stewardship of the UN, UHC is likely
to play a central role in the post-MDG development world,
beyond 2015. With the British Prime Minister having
served as the co-chair of the post-MDG agenda panel, now
is a unique opportunity for the UK Government to system-
atise its response to the demand for knowledge and tech-
nical assistance to learn from the NHS experience, whilst
capitalising on the possibility of working across govern-
ment sectors to address the UK’s foreign policy, trade and
aid priorities.
This is the right time to commission a full economic
analysis of both the costs and tangible and intangible
(including those stemming from development and global
health diplomacy) benefits of investing in promoting the
Table 3 An example of a system-wide approach attracting cross-government support [27]
NICE International: Working across the British Government
NICE International, a non-profit, cost-recouping division of the National
Institute for Health and Clinical Excellence, was set up by NICE’s Board
in 2008, to support overseas governments with developing and
applying the necessary technical and institutional capacity to
improving the quality and efficiency of their healthcare systems.a
To achieve this, NICE International mobilises its own as well as
broader NHS and non-NHS resources, front-line NHS professionals
and UK Universities.
Traditionally relied on non-UK funding, from the World Bank, national
governments of client countries, the European Commission, regional
development banks such as the Inter American Development Bank,
and, increasingly on philanthropic funders such as the Rockefeller
Foundation and the Bill and Melinda Gates Foundation.
During the second half of 2012, NICE International has received
substantive funding support from the Department of International
Development supplemented by funding from the Department of
Health and small scale Foreign Office support mostly from FCO
China, Brazil and the Philippines. NICE International has also been
more directly involved in UKTI trade collaborative propositions,
together with UK companies, in China and the Middle East
NICE International is perhaps one example (with its strengths
and weaknesses) for scaling up, across other parts of the NHS,
cross-government working, driven by overseas governments’
requests for NHS expertise
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native of sole (and often short-termist and fragmented)
commercial focus. This could include an options analysis
of the governance and business arrangements of such
an initiative, which could range from the NICE Inter-
national low cost, opportunistic bottom-up approach
to international engagements (see Table 3), to a more coor-
dinated strategy, with a dedicated cross-government office,
aligned with the new and emerging NHS infrastructure
across England.Endnotes
aUN Secretary-General Appoints High-level Panel on
Post-2015 Development Agenda: http://www.un.org/sg/
offthecuff/?nid=2455
bSpecial report: ‘This can’t go on’ - NHS chiefs urge
new debate on health service reforms, The Independ-




cFor a transcript of the First BRICS Health Ministers
Meeting in Beijing and the resulting Beijing Declar-
ation of July 2011, see: http://www.cfr.org/global-health/
brics-health-ministers-meeting——beijing-declaration/
p25620
dSee for example, from the BBC: Peers support gov-
ernment on NHS despite Labour ‘privatisation’ warnings
http://www.bbc.co.uk/news/uk-politics-22268417 April
2013 and from the Guardian, The NHS at 65: chaos,
queues and mounting costs, July 2013 http://www.
guardian.co.uk/commentisfree/2013/jul/05/nhs-65-chaos-
queues-mounting-costs
eChina Health Policy Support Programme, see: http://
www.china.org.cn/english/2005/Oct/146196.htm and http://




gSee Speech by Andrew Mitchell, International Develop-
ment Secretary, at the Emerging Powers and the Inter-






iSee written Ministerial Statement by the Secretary
of State for International Development Justine Greening
on aid to India in November 2012: https://www.gov.
uk/government/policies/helping-developing-countries-
economies-to-grow
jThe government’s shift towards an aid for trade
agenda, with an emphasis on growth as a mechanism
for combatting poverty has been widely reported in the
press. See for example: http://www.guardian.co.uk/global-
development/2013/feb/07/justine-greenign-dfid-investment-
africa-economic-growth and the Development Secretary’s
original speech, setting out her priorities for UK aid in the
coming years, hosted by ONE Campaign UK in February
2013: https://www.gov.uk/government/speeches/justine-
greening-development-in-transition
kThe government’s shift towards an aid for trade
agenda, with an emphasis on growth as a mechanism
for combatting poverty has been widely reported in the
press. See for example: http://www.guardian.co.uk/global-
development/2013/feb/07/justine-greenign-dfid-investment-
africa-economic-growth and the Development Secretary’s
original speech, setting out her priorities for UK aid in the
coming years, hosted by ONE Campaign UK in February
2013: https://www.gov.uk/government/speeches/justine-
greening-development-in-transition
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global_health_by_elevating_diplomacy
mSee US Secretary of State’s Hillary Clinton speech about
the Obama administration’s Global Health Initiative to fac-
ulty and students at the Johns Hopkins School of Advanced
International Studies in August 2010: What does global





nSee Medical Education Cooperation with Cuba: http://
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